
University of Bristol biotech spin-out Zentraxa is raising £500,000 to start full trials of its unique manufacturing process that produces biological adhesives for use in the healthcare sector. The firm, which has its roots in the university’s Synthetic Biology Research Centre, hopes to commercialise the produce, called Zentide. It...